Clinical Trial Update: Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen [Phase 2]

View source ↗

Summary

A Phase 2 open-label trial evaluated exemestane with or without celecoxib in postmenopausal women with advanced breast cancer that progressed on tamoxifen; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromasin (exemestane)
• Celecoxib (Celecoxib)

Snippet

Sponsor: Pfizer | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2010-02-25